Olaparib tablets, 150 mg
21-VIN-0166/SAN-0647
Phase 1 small_molecule completed
Quick answer
Olaparib tablets, 150 mg for Ovarian Cancer is a Phase 1 program (small_molecule) at Sandoz Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sandoz Pty Ltd
- Indication
- Ovarian Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed